SuggestSoft.com

Winlog

WinLog V1.1.2

No Image WinLog software captures and relays syslog messages (unmodified) sent by different network devices like routers, managed switches and hosts. These captured messages are logged into logfile and converted to easy readable format. From this log file you can filter out messages based on different criteria. WinLog also can be used as a log reader/filter for raw syslog log files generated by WinLog itself. With strong log filtering capabilities of WinLog






No Image
Winlog Lite 2.06.27

Winlog Lite is a powerful and easy to use SCADA/HMI software for the supervision of industrial and civil plants. An integrated development environment provides different tools (Gate Builder, Template Builder, Code Builder) for the easy and intuitive creation of multilanguage applications. Communication with most popular devices (PLCs, PID controllers,I/O modules, OPC servers, etc.) is ensured by an extensive library of drivers.

modbus, system, industrial, data acquisition, supervisory, software, free, freeware, siemens, scada, omron, communication





WinLogic 1.7: Logical Game with Various Difficulty Levels for All Age Categories - Master Mind
WinLogic 1.7

The game develops logical thinking, smartness, tenacity, the ability to combine facts, to classify and perceive the given system and environment in a very effective and relaxing way. Thanks to the simplifying settings the game is also suitable for small children.

logical game, master mind, invicta plastics, logik, logic, winlogic



PPedia Task Manager Svchost Edition 1.02: Free Task manager with built-in process library, identify malware and spyware
PPedia Task Manager Svchost Edition 1.02

Free Task manager with built-in process library. Do you know what process names like svchost, winlogon, taskmgr, rundll32, jusched, btstac~1, setup_wm, alg.exe, crss.exe or help.exe or ctfmon mean? The software and http://www.ppedia.com help you to distinguish between system processes, known trustworthy programs and malware.

spyware, malware, ctfmon, library, removal, winlogon, keylogger, task manager, process, svchost, svchost exe, list



WinLog Assist 2.0: Win Log Assist is a PC time-keeping tool.
WinLog Assist 2.0

Win Log Assist is a PC time-keeping tool. The program logs the exact time when the user worked with the applications and you will see on what kind of work your time has been spent. The internal program database stores the information on each day so you’re able to watch the every day data in details. The program is easy-to-use and has low system requirements.

time tracker, time management, time keeping tool



No Image
LogonExpert 4.2.2

LogonExpert is a Windows automatic logon tool for your home/office computer or corporate server. LogonExpert quickly and securely logs in a user by direct interaction with the WinLogon system without using the registry. Your computer can be protected even after automatic logon by the desktop being locked at startup. LogonExpert uses a strong encryption algorithm to store login data. Build-in scheduler allows to delay, plan your logon/logooffs.

windows password bypass, logon, autologon xp 2000 2003, auto logon windows, login, bypass admin password, startup password, log on, administrator password bypass, server autologon, disable windows password, automatic logon, automatic login




More Results: 1  

World IT News

  • PC Mall Chooses iZ3D 22-Inch Widescreen 3D MonitorsPopular 3D Monitor Now Features New Drivers for 64 Bit Compatibility, CrossFireX and Open GL Quad Buffer Support
  • New IBM Consulting Offerings Help Clients Be Greener, More EthicalImproving Corporate Social Responsibility Can Grow Revenue, Market Share
  • Are Your Computers Sky Divers?BURBANK, CA--(Marketwire - June 30, 2008) - Astute risk management defines success in theinsurance industry. Premiums charged to the company's customers reflectthat relation of risk to profit, while the riskiest ventures are avoidedentirely. Translating risk to the IT world would likely bring securitysoftware solutions to mind. Not managing those risks can result in dataloss, corporate espionage, and other nasty events. It may come as a surprise that file fragmentation can be risky businesstoo. Fragmentation creates many more unattractive side effects than a slowcomputer. The insurance policyholder who smokes is a higher risk than theone who does not, and subsequently they pay a higher premium.
  • Labwire Completes First Conversion of USIS BusinessHOUSTON, TX--(Marketwire - June 30, 2008) - Labwire, Inc. ( PINKSHEETS : LBWR ), a leadingprovider of employee screening solutions and canine security andsurveillance services, announced today that it has completed the firstconversion of business under the USIS agreement. "This is a very important accomplishment for us," commented Mr. DexterMorris, Chairman and Chief Executive Officer of Labwire. "Our team workedwell with USIS personnel, and the conversion was completed smoothly and onschedule. We are already planning the next interfaces and data transfersand exploring additional business possibilities with USIS. I am veryexcited about the potential of this strategic relationship."
  • FDAAdvisoryCommittee.com to Webcast the FDA Endocrinologic and Metabolic Drugs Advisory Committee Hearing on July 1st & 2nd in Conjunction With TalkPointNEW YORK, NY--(Marketwire - June 30, 2008) - TalkPoint , leading provider of theTools, Technology and Services for Interactive Internet Broadcasting, and FDAAdvisoryCommittee.com , the leadingwebcast and DVD source for FDA Advisory Committee Meetings, today announcedthat TalkPoint will be powering the Endocrinologic and Metabolic DrugsAdvisory Committee Meeting scheduled for July 1st & 2nd. The July Endocrinologic and Metabolic Drugs Advisory Committee Meeting isbeing held to further discuss whether to insist that new diabetes drugshave a positive impact on cardiovascular disease and life span. At issue iswhat benchmarks the FDA should use to approve diabetes drugs. The two-daymeeting of FDA officials and outside medical experts, set to start Tuesday,will discuss whether the agency should require additional, more rigorousbenchmarks, such as proof a drug ultimately lowers risks for cardiovasc